KATE CRAIGHEAD: Open Payments
NPI 1316475239 · LYNCHBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$790 in 21 payments from 7 companies in 2025. Trend: 2023 $397 · 2024 $1,110 · 2025 $790
Food & beverage: $790
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 8 | $246 |
| ABBVIE INC. | 5 | $175 |
| Organon LLC | 2 | $127 |
| Regeneron Healthcare Solutions, Inc. | 2 | $116 |
| Galderma Laboratories, L.P. | 1 | $48 |
| Janssen Biotech, Inc. | 1 | $41 |
| UCB, Inc. | 2 | $37 |
Products named: Zoryve, VTAMA, DUPIXENT, BOTOX, SKYRIZI, TREMFYA, Bimzelx, RINVOQ.
Industry payments across VA — which companies pay providers there.
